Diabetes Drug Effective in Early Alzheimer's

Rosiglitazone: "researchers presented data on a 24-week pilot trial of the diabetes drug rosiglitazone in patients with mild cognitive impairment (MCI) or very mild Alzheimer's disease. The 20 subjects who received rosiglitazone � a drug that boosts insulin activity � did not decline in their performance on memory and attention tests, whereas the 10 patients who received placebo declined at a rate typical for Alzheimer �s. "